Analysis of the fibroblast growth factor system reveals alterations in a mouse model of spinal muscular atrophy

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Hensel, Niko ^a,b   Ratzka, Andreas ^a   Brinkmann, Hella ^a   Klimaschewski, Lars ^c   Grothe, Claudia ^a,b   Claus, Peter ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SURVIVAL MOTOR NEURON PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACK MUSCLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; MOTONEURON; MOUSE; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TARGETING; RECEPTOR UPREGULATION; SPINAL CORD; SPINAL MUSCULAR ATROPHY; SYMPTOMATOLOGY; TISSUE DISTRIBUTION; ANIMAL; CHEMISTRY; DISEASE MODEL; METABOLISM; MUSCLE; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTORS; MAP KINASE SIGNALING SYSTEM; MICE; MUSCLES; MUSCULAR ATROPHY, SPINAL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SMN COMPLEX PROTEINS; SPINAL CORD;

EID: 84856822983     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031202     Document Type: Article

References (65)

1. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, et al. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80: 155-165.
2. Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, et al. (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 16: 265-269.
3. Lorson CL, Hahnen E, Androphy EJ, Wirth B, (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A 96: 6307-6311.
4. Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, et al. (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8: 1177-1183.
5. Taylor JE, Thomas NH, Lewis CM, Abbs SJ, Rodrigues NR, et al. (1998) Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy. Eur J Hum Genet 6: 467-474.
6. Wirth B, Brichta L, Schrank B, Lochmuller H, Blick S, et al. (2006) Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet 119: 422-428.
7. Gavrilina TO, McGovern VL, Workman E, Crawford TO, Gogliotti RG, et al. (2008) Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect. Hum Mol Genet 17: 1063-1075.
8. McWhorter ML, Monani UR, Burghes AH, Beattie CE, (2003) Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J Cell Biol 162: 919-931.
9. Martinez-Hernandez R, Soler-Botija C, Also E, Alias L, Caselles L, et al. (2009) The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation. J Neuropathol Exp Neurol 68: 474-481.
10. Chang HC, Dimlich DN, Yokokura T, Mukherjee A, Kankel MW, et al. (2008) Modeling spinal muscular atrophy in Drosophila. PLoS One 3: e3209.
11. Chan YB, Miguel-Aliaga I, Franks C, Thomas N, Trulzsch B, et al. (2003) Neuromuscular defects in a Drosophila survival motor neuron gene mutant. Hum Mol Genet 12: 1367-1376.
12. Guettier-Sigrist S, Hugel B, Coupin G, Freyssinet JM, Poindron P, et al. (2002) Possible pathogenic role of muscle cell dysfunction in motor neuron death in spinal muscular atrophy. Muscle Nerve 25: 700-708.
13. Itoh N, Ornitz DM, (2011) Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem 149: 121-130.
14. Eash J, Olsen A, Breur G, Gerrard D, Hannon K, (2007) FGFR1 inhibits skeletal muscle atrophy associated with hindlimb suspension. BMC Musculoskelet Disord 8: 32.
15. Marics I, Padilla F, Guillemot JF, Scaal M, Marcelle C, (2002) FGFR4 signaling is a necessary step in limb muscle differentiation. Development 129: 4559-4569.
16. Zhao P, Caretti G, Mitchell S, McKeehan WL, Boskey AL, et al. (2006) Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway. J Biol Chem 281: 429-438.
17. Garces A, Nishimune H, Philippe JM, Pettmann B, deLapeyriere O, (2000) FGF9: a motoneuron survival factor expressed by medial thoracic and sacral motoneurons. J Neurosci Res 60: 1-9.
18. Grothe C, Unsicker K, (1992) Basic fibroblast growth factor in the hypoglossal system: specific retrograde transport, trophic, and lesion-related responses. J Neurosci Res 32: 317-328.
19. Li PP, Chen C, Lee CW, Madhavan R, Peng HB, (2011) Axonal filopodial asymmetry induced by synaptic target. Mol Biol Cell 22: 2480-2490.
20. Hausott B, Schlick B, Vallant N, Dorn R, Klimaschewski L, (2008) Promotion of neurite outgrowth by fibroblast growth factor receptor 1 overexpression and lysosomal inhibition of receptor degradation in pheochromocytoma cells and adult sensory neurons. Neuroscience 153: 461-473.
21. Slotkin TA, Seidler FJ, Fumagalli F, (2008) Targeting of neurotrophic factors, their receptors, and signaling pathways in the developmental neurotoxicity of organophosphates in vivo and in vitro. Brain Res Bull 76: 424-438.
22. Slotkin TA, Seidler FJ, Fumagalli F, (2007) Exposure to organophosphates reduces the expression of neurotrophic factors in neonatal rat brain regions: similarities and differences in the effects of chlorpyrifos and diazinon on the fibroblast growth factor superfamily. Environ Health Perspect 115: 909-916.
23. Hausott B, Kurnaz I, Gajovic S, Klimaschewski L, (2009) Signaling by neuronal tyrosine kinase receptors: relevance for development and regeneration. Anat Rec (Hoboken) 292: 1976-1985.
24. Weston CA, Teressa G, Weeks BS, Prives J, (2007) Agrin and laminin induce acetylcholine receptor clustering by convergent, Rho GTPase-dependent signaling pathways. J Cell Sci 120: 868-875.
25. Nölle A, Zeug A, Bergeijk Jv, Tonges L, Gerhard R, et al. (2011) The Spinal Muscular Atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin. Hum Mol Genet in press. doi:10.1093/hmg/ddr1425.
26. Bowerman M, Beauvais A, Anderson CL, Kothary R, (2010) Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model. Hum Mol Genet 19: 1468-1478.
27. Stachowiak MK, Fang X, Myers JM, Dunham SM, Berezney R, et al. (2003) Integrative nuclear FGFR1 signaling (INFS) as a part of a universal "feed-forward-and-gate" signaling module that controls cell growth and differentiation. J Cell Biochem 90: 662-691.
28. Claus P, Doring F, Gringel S, Muller-Ostermeyer F, Fuhlrott J, et al. (2003) Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein. J Biol Chem 278: 479-485.
29. Claus P, Bruns AF, Grothe C, (2004) Fibroblast growth factor-2(23) binds directly to the survival of motoneuron protein and is associated with small nuclear RNAs. Biochem J 384: 559-565.
30. Bruns AF, van Bergeijk J, Lorbeer C, Nolle A, Jungnickel J, et al. (2009) Fibroblast growth factor-2 regulates the stability of nuclear bodies. Proc Natl Acad Sci U S A 106: 12747-12752.
31. Sen A, Yokokura T, Kankel MW, Dimlich DN, Manent J, et al. (2011) Modeling spinal muscular atrophy in Drosophila links Smn to FGF signaling. J Cell Biol 192: 481-495.
32. Hsieh-Li HM, Chang JG, Jong YJ, Wu MH, Wang NM, et al. (2000) A mouse model for spinal muscular atrophy. Nat Genet 24: 66-70.
33. Riessland M, Ackermann B, Forster A, Jakubik M, Hauke J, et al. (2010) SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum Mol Genet 19: 1492-1506.
34. Yaffe D, Saxel O, (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727.
35. Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, et al. (1992) Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 194: 209-221.
36. Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford TO, et al. (1997) The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 6: 1205-1214.
37. Mohammadi M, Froum S, Hamby JM, Schroeder MC, Panek RL, et al. (1998) Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J 17: 5896-5904.
38. Skaper SD, Kee WJ, Facci L, Macdonald G, Doherty P, et al. (2000) The FGFR1 inhibitor PD 173074 selectively and potently antagonizes FGF-2 neurotrophic and neurotropic effects. J Neurochem 75: 1520-1527.
39. Steinberg F, Zhuang L, Beyeler M, Kalin RE, Mullis PE, et al. (2010) The FGFRL1 receptor is shed from cell membranes, binds fibroblast growth factors (FGFs), and antagonizes FGF signaling in Xenopus embryos. J Biol Chem 285: 2193-2202.
40. Gringel S, van Bergeijk J, Haastert K, Grothe C, Claus P, (2004) Nuclear fibroblast growth factor-2 interacts specifically with splicing factor SF3a66. Biol Chem 385: 1203-1208.
41. Umemori H, (2009) Weaving the neuronal net with target-derived fibroblast growth factors. Dev Growth Differ 51: 263-270.
42. Stewart CE, Rotwein P, (1996) Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 271: 11330-11338.
43. Kuninger D, Wright A, Rotwein P, (2006) Muscle cell survival mediated by the transcriptional coactivators p300 and PCAF displays different requirements for acetyltransferase activity. Am J Physiol Cell Physiol 291: C699-709.
44. Hughes RA, Sendtner M, Goldfarb M, Lindholm D, Thoenen H, (1993) Evidence that fibroblast growth factor 5 is a major muscle-derived survival factor for cultured spinal motoneurons. Neuron 10: 369-377.
45. Ratzka A, Baron O, Grothe C, (2011) FGF-2 Deficiency Does Not Influence FGF Ligand and Receptor Expression during Development of the Nigrostriatal System. PLoS One 6: e23564.
46. Weinstein M, Xu X, Ohyama K, Deng CX, (1998) FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 125: 3615-3623.
47. Grothe C, Brand-Saberi B, Wilting J, Christ B, (1996) Fibroblast growth factor receptor 1 in skeletal and heart muscle cells: expression during early avian development and regulation after notochord transplantation. Dev Dyn 206: 310-317.
48. Shafey D, Cote PD, Kothary R, (2005) Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology. Exp Cell Res 311: 49-61.
49. Walker MP, Rajendra TK, Saieva L, Fuentes JL, Pellizzoni L, et al. (2008) SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain. Hum Mol Genet 17: 3399-3410.
50. Rajendra TK, Gonsalvez GB, Walker MP, Shpargel KB, Salz HK, et al. (2007) A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle. J Cell Biol 176: 831-841.
51. Mutsaers CA, Wishart TM, Lamont DJ, Riessland M, Schreml J, et al. (2011) Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum Mol Genet.
52. Bosch-Marce M, Wee CD, Martinez TL, Lipkes CE, Choe DW, et al. (2011) Increased IGF-1 in muscle modulates the phenotype of severe SMA mice. Hum Mol Genet 20: 1844-1853.
53. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, et al. (1995) Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270: 12109-12116.
54. Soundararajan P, Fawcett JP, Rafuse VF, (2010) Guidance of postural motoneurons requires MAPK/ERK signaling downstream of fibroblast growth factor receptor 1. J Neurosci 30: 6595-6606.
55. van Bergeijk J, Rydel-Konecke K, Grothe C, Claus P, (2007) The spinal muscular atrophy gene product regulates neurite outgrowth: importance of the C terminus. FASEB J 21: 1492-1502.
56. Hanafusa H, Torii S, Yasunaga T, Nishida E, (2002) Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol 4: 850-858.
57. Markus A, Zhong J, Snider WD, (2002) Raf and akt mediate distinct aspects of sensory axon growth. Neuron 35: 65-76.
58. Lin WF, Chen CJ, Chang YJ, Chen SL, Chiu IM, et al. (2009) SH2B1beta enhances fibroblast growth factor 1 (FGF1)-induced neurite outgrowth through MEK-ERK1/2-STAT3-Egr1 pathway. Cell Signal 21: 1060-1072.
59. Lingor P, Tonges L, Pieper N, Bermel C, Barski E, et al. (2008) ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells. Brain 131: 250-263.
60. Subramaniam S, Unsicker K, (2010) ERK and cell death: ERK1/2 in neuronal death. FEBS J 277: 22-29.
61. Jungnickel J, Klutzny A, Guhr S, Meyer K, Grothe C, (2005) Regulation of neuronal death and calcitonin gene-related peptide by fibroblast growth factor-2 and FGFR3 after peripheral nerve injury: evidence from mouse mutants. Neuroscience 134: 1343-1350.
62. Nakamura S, Todo T, Motoi Y, Haga S, Aizawa T, et al. (1999) Glial expression of fibroblast growth factor-9 in rat central nervous system. Glia 28: 53-65.
63. Medhurst AD, Harrison DC, Read SJ, Campbell CA, Robbins MJ, et al. (2000) The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J Neurosci Methods 98: 9-20.
64. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
65. Ehrenreiter K, Piazzolla D, Velamoor V, Sobczak I, Small JV, et al. (2005) Raf-1 regulates Rho signaling and cell migration. J Cell Biol 168: 955-964.